Mapping of the lung megakaryocytes: A role in pathogenesis of idiopathic pulmonary arterial hypertension?

Lefrançais, 2017, The lung is a site of platelet biogenesis and a reservoir for haematopoietic progenitors, Nature, 544, 105, 10.1038/nature21706 Trowbridge, 1982, Evidence for a theory of physical fragmentation of megakaryocytes, implying that all platelets are produced in the pulmonary circulation, Thromb. Res., 28, 461, 10.1016/0049-3848(82)90163-3 Martin, 1983, Abnormal intrapulmonary platelet production: a possible cause of vascular and lung disease, Lancet, 1, 793, 10.1016/S0140-6736(83)91851-2 Levine, 1993, Circulating megakaryocytes: delivery of large numbers of intact, mature megakaryocytes to the lungs, Eur. J. Haematol., 51, 233, 10.1111/j.1600-0609.1993.tb00637.x Pedersen, 1978, Occurrence of megakaryocytes in various vessels and their retention in the pulmonary capillaries in man, Scand. J. Haematol., 21, 369, 10.1111/j.1600-0609.1978.tb00381.x T.M. Scheinin, A.P. Koivuniemi, Megakaryocytes in the pulmonary circulation, Blood 22 (1963) 82–87.https://doi.org/10.1182/blood.V22.1.82.82. Yeung, 2020, Lung megakaryocytes display distinct transcriptional and phenotypic properties, Blood Adv., 4, 6204, 10.1182/bloodadvances.2020002843 Sharma, 1986, Pulmonary megakaryocytes: "missing link" between cardiovascular and respiratory disease?, J. Clin. Pathol., 39, 969, 10.1136/jcp.39.9.969 Soares, 1992, Increased numbers of pulmonary megakaryocytes in patients with arterial pulmonary tumour embolism and with lung metastases seen at necropsy, J. Clin. Pathol., 45, 140, 10.1136/jcp.45.2.140 Brown, 1994, The megakaryocyte platelet system and vascular disease, Eur. J. Clin. Invest., 24, 9, 10.1111/j.1365-2362.1994.tb02419.x Mandal, 2007, Megakaryocytes and platelet homeostasis in diffuse alveolar damage, Exp. Mol. Pathol., 83, 327, 10.1016/j.yexmp.2007.08.005 Zanjani, 2012, Platelets in pulmonary hypertension: a causative role or a simple association?, Iran. J. Pediatr., 22, 145 Kazimierczyk, 2018, The role of platelets in the development and progression of pulmonary arterial hypertension, Adv. Med. Sci., 63, 312, 10.1016/j.advms.2018.04.013 Kazimierczyk, 2019, Increased platelet content of SDF-1alpha is associated with worse prognosis in patients with pulmonary prterial hypertension, Platelets, 30, 445, 10.1080/09537104.2018.1457780 Zheng, 2015, Platelet distribution width and mean platelet volume in idiopathic pulmonary arterial hypertension, Heart Lung Circ., 24, 566, 10.1016/j.hlc.2014.11.025 Humbert, 1998, Platelet-derived growth factor expression in primary pulmonary hypertension: comparison of HIV seropositive and HIV seronegative patients, Eur. Respir. J., 11, 554, 10.1183/09031936.98.11030554 Salven, 1999, Leukocytes and platelets of patients with cancer contain high levels of vascular endothelial growth factor, Clin. Cancer Res., 5, 487 Italiano, 2008, Angiogenesis is regulated by a novel mechanism: pro- and antiangiogenic proteins are organized into separate platelet alpha granules and differentially released, Blood, 111, 1227, 10.1182/blood-2007-09-113837 Lee, 2007, Autocrine VEGF signaling is required for vascular homeostasis, Cell, 130, 691, 10.1016/j.cell.2007.06.054 Andrae, 2008, Role of platelet-derived growth factors in physiology and medicine, Genes Dev., 22, 1276, 10.1101/gad.1653708 Rhee, 2004, The functional role of blood platelet components in angiogenesis, Thromb. Haemost., 92, 394 Collados, 1999, Characterization of von Willebrand factor in primary pulmonary hypertension, Heart Vessels, 14, 246, 10.1007/BF01747854 Kéreveur, 2000, High plasma serotonin levels in primary pulmonary hypertension. Effect of long-term epoprostenol (prostacyclin) therapy, Arterioscler. Thromb. Vasc. Biol., 20, 2233, 10.1161/01.ATV.20.10.2233 Busl, 2015, Neurogenic pulmonary edema, Crit. Care Med., 43, 1710, 10.1097/CCM.0000000000001101